Designation, Amount and Par Value. The series of preferred stock shall be designated as the Corporation’s Series C Convertible Preferred Stock (the “Series C Preferred Stock”) and the number of shares so designated shall be 95,388. Each share of Series C Preferred Stock shall have a par value of $0.001 per share. The shares of Series C Preferred Stock shall initially be issued and maintained in the form of securities held in book-entry form.
Appears in 2 contracts
Sources: Agreement to Amend Series C Convertible Preferred Stock (ReShape Lifesciences Inc.), Agreement to Amend Series C Convertible Preferred Stock (ReShape Lifesciences Inc.)
Designation, Amount and Par Value. The series of preferred stock shall be designated as the Corporation’s Series C Convertible Preferred Stock (the “Series C Preferred Stock”) ), and the number of shares so designated shall be 95,388. Each share of Series C Preferred Stock shall have a par value of $0.001 per share. The shares of Series C Preferred Stock shall initially be issued and maintained in the form of securities held in book-entry form1,250,010.* * CONTINUED ON THE ATTACHED
Appears in 1 contract
Designation, Amount and Par Value. The series of preferred stock Preferred Stock shall be designated as the Corporation’s Series C Convertible Preferred Stock (the “Series C Preferred Stock”) and the number of shares so designated shall be 95,388400, which shall not be subject to increase without any consent of the holders of the Series C Preferred Stock (each a “Holder” and collectively, the “Holders”) as required by applicable law. Each share of Series C Preferred Stock shall have a par value of $0.001 per share. The shares of Series C Preferred Stock shall initially be issued and maintained in the form of securities held in book-entry form.
Appears in 1 contract
Sources: Convertible Preferred Stock Purchase Agreement (POSITIVEID Corp)
Designation, Amount and Par Value. The series of preferred stock shall be designated as the Corporation’s its Series C Convertible Preferred Stock (the “Series C Preferred StockPreferred”) and the number of shares so designated shall be 95,388up to 5,000,000 (which shall not be subject to increase without the written consent of all of the holders of the Series C Preferred (each, a “Holder” and collectively, the “Holders”). Each share of Series C Preferred Stock shall have a par value of $0.001 per share. The shares of Series C Preferred Stock shall initially be issued share and maintained in a stated value equal to $0.50 per share (the form of securities held in book-entry form“Stated Value”).
Appears in 1 contract
Sources: Subscription Agreement (Star Mountain Resources, Inc.)
Designation, Amount and Par Value. The series of preferred stock shall be designated as the Corporation’s Series C Convertible Preferred Stock (the “"Series C Preferred Stock”") and the number of shares so designated shall be 95,388500,000. Each share of Series C Preferred Stock shall have a par value of $0.001 per share. The shares of Series C Preferred Stock shall initially be issued and maintained in the form of securities held in book-entry form.
Appears in 1 contract
Designation, Amount and Par Value. The This series of preferred stock Preferred Stock shall be designated as the Corporation’s Series C Convertible B Preferred Stock (the “Series C Preferred Stock”) and the number of shares so designated shall be 95,388six hundred (600). Each share of Series C B Preferred Stock shall have a par value of $0.001 per share. The shares of Series C Preferred Stock shall initially be issued and maintained in the form of securities held in book-entry form.
Appears in 1 contract
Sources: Securities Purchase Agreement (BioSig Technologies, Inc.)
Designation, Amount and Par Value. The series of preferred stock shall be designated as the Corporation’s Series C Convertible Preferred Stock (the “Series C Preferred Stock”) ), and the number of shares so designated shall be 95,3881,250,010. Each share of Series C Preferred Stock shall have a no par value of and a stated value equal to $0.001 per share. The shares of Series C Preferred Stock shall initially be issued and maintained in 2.80 (the form of securities held in book-entry form“Stated Value”).
Appears in 1 contract
Designation, Amount and Par Value. The series of preferred stock Preferred Stock shall be designated as the Corporation’s Series C Convertible Preferred Stock (the “Series C Preferred Stock”) and the number of shares so designated shall be 95,3881,500 (which shall not be subject to increase without any consent of the holders of the Series C Preferred Stock (each a “Holder” and collectively, the “Holders”) that may be required by applicable law. Each share of Series C Preferred Stock shall have a par value of $0.001 0.0001 per share. The shares of Series C Preferred Stock shall initially be issued and maintained in the form of securities held in book-entry form.
Appears in 1 contract
Sources: Preferred Stock Purchase Agreement (MedClean Technologies, Inc.)
Designation, Amount and Par Value. The series of preferred stock shall be designated as the Corporation’s Series C Convertible Preferred Stock (the “"Series C Preferred Stock”") and the number of shares so designated shall be 95,388200,000. Each share of Series C Preferred Stock shall have a par value of $0.001 .001 per share. The shares of Series C Preferred Stock shall initially be issued and maintained in the form of securities held in book-entry form.
Appears in 1 contract
Sources: Purchase Agreement (GSV Inc)
Designation, Amount and Par Value. The There is hereby designated a series of the Corporation's preferred stock shall be designated as the Corporation’s Series C A Convertible Preferred Stock (the “"Series C A Preferred Stock”) "), and the number of shares so designated shall be 95,38876,500. Each share of Series C A Preferred Stock shall have a par value of $0.001 1.00 per share. The shares "Stated Value" for each share of Series C A Preferred Stock shall initially be issued and maintained in the form of securities held in book-entry formequal $1,000.00.
Appears in 1 contract
Sources: Preferred Stock Purchase Agreement (Alpine Group Inc /De/)
Designation, Amount and Par Value. (a) The series of preferred stock shall be designated as the Corporation’s its Series C Convertible Preferred Stock (the “Series C Preferred StockPreferred”) and the number of shares so designated shall be 95,388up to 3,500,000 (which shall not be subject to increase without the written consent of all of the holders of the Series C Preferred (each, a “Holder” and collectively, the “Holders”)). Each share of Series C Preferred Stock shall have a par value of $0.001 per share. The shares of Series C Preferred Stock shall initially be issued and maintained in the form of securities held in book-entry form.
Appears in 1 contract
Sources: Stock Purchase Agreement (Great Plains Holdings, Inc.)
Designation, Amount and Par Value. The series of preferred stock Preferred Stock shall be designated as the Corporation’s Series C Convertible Preferred Stock (the “Series C Preferred Stock”) and the number of shares so designated shall be 95,388Eighty-Nine Million Nine Hundred Ninety-Nine Thousand Nine-Hundred Ninety Nine (89,999,999). Each share of the Series C Preferred Stock shall have a par value of $0.001 per share. The shares of Series C Preferred Stock shall initially be issued and maintained in the form of securities held in book-entry form0.001.
Appears in 1 contract
Sources: Director Agreement